✦ LIBER ✦

The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic

✍ Scribed by Glen J. Pearson; Gordon A. Francis; Jacques S. Romney; Dawna M. Gilchrist; Andrea Opgenorth; Gabor T. Gyenes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EZETIMIBE IN THE MANAGEMENT OF PATIENTS

✍ Walji, S.; Neuwirth, C.; Sarwar, R.; Aitman, T.; Seed, M.; Naoumova, R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Effectiveness of a specialist nurse-led

✍ Cr McLoughney; ASA Khan; Dr AB Ahmed 📂 Article 📅 2007 🏛 Maney Publishing 🌐 English ⚖ 206 KB 👁 1 views

Cardiovascular risk stratification and m

✍ Faden, G.; Viapiana, O.; Fischetti, F.; Faganello, G.; Gatti, D.; Tarantini, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Reduction of High-Risk Polypharmacy Drug

✍ David S. Craig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Reduction of High-Risk Polypharmacy Drug

✍ Dr. Barbara J. Zarowitz; Ms. Lesia A. Stebelsky; Dr. Bruce K. Muma; Dr. Tanya M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Effects of intensive cardiovascular risk

✍ Dirk C. Felmeden; Charles G. Spencer; Funmi M. Belgoro; Andrew D. Blann; Gareth 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB